serena williams glp 1 commercial Ro makes Super Bowl debut with to shift GLP-1 narrative from 'vanity' to 'vitals' Serena Williams on Taking a

The compounded version contains the same active ingredient, prescribed and dosed by a licensed provider based on your individual health profile

Additive cardiovascular risk reduction of GLP1a and SGLT2i in diabetic patients with atherosclerotic disease

Some medical conditions and medications contribute to weight gain or make weight management more challenging

Farmer L

A seminal July 2022 study in The New England Journal of Medicine found that those taking a lower dose of tirzepatide achieved an average weight reduction of 16%, or 35.5 pounds (16 kilograms), in about a year

McGuire, found that oral semaglutide reduced major adverse cardiovascular events (MACE) to 3.1 events per 100 person-years, compared to 3.7 events in the placebo group a 14% reduction (HR 0.86) over a median follow-up of 49.5 months